Logo
P

Plexium

88 employees

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Health Care
Medical

Date founded

2018

Funding rounds raised

Total raised

$102M

from 18 investors over 18 rounds

P

Plexium raised $102M on February 23, 2022

Investors: TCG X, The Column Group, Lux Capital, Surveyor Capital, Pappas Capital, SoftBank Investment Advisers, M Ventures, Neotribe Ventures and RA Capital Management, L.P.

P

Plexium raised $35M on January 19, 2021

Investors: DCVC Bio, The Column Group and Lux Capital

P

Plexium raised $28M on October 17, 2019

Investors: The Column Group, CRV and Neotribe Ventures

P

Plexium raised undisclosed on April 25, 2019

Investors: DCVC Bio

P

Plexium raised undisclosed on October 1, 2018

Investors: DCVC Bio

P

Plexium raised undisclosed on February 1, 2018

Investors: CRV

FAQ